Allworth Financial’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.2K Buy
5,257
+1,358
+35% +$10.4K ﹤0.01% 2490
2025
Q4
$37.9K Buy
3,899
+90
+2% +$765 ﹤0.01% 2387
2025
Q3
$16K Buy
3,809
+3,691
+3,128% +$23.6K ﹤0.01% 2839
2025
Q2
$1.1K Sell
118
-170
-59% -$1.48K ﹤0.01% 3935
2025
Q1
$2.61K Sell
288
-59
-17% -$730 ﹤0.01% 3095
2024
Q4
$4.52K Sell
347
-62
-15% -$753 ﹤0.01% 2811
2024
Q3
$4.48K Buy
409
+27
+7% +$274 ﹤0.01% 2618
2024
Q2
$3.78K Buy
382
+126
+49% +$878 ﹤0.01% 2644
2024
Q1
$2.09K Buy
+256
New +$2.1K ﹤0.01% 2785
2023
Q4
Sell
-13
Closed -$223 3590
2023
Q3
$223 Hold
13
﹤0.01% 3219
2023
Q2
$302 Hold
13
﹤0.01% 3019
2023
Q1
$230 Hold
13
﹤0.01% 2977
2022
Q4
$354 Hold
13
﹤0.01% 2707
2022
Q3
$0 Buy
+13
New +$248 ﹤0.01% 3038

Other funds holding REPL

Allworth Financial's REPL Position: Q1 2026 in Review

Allworth Financial increased its Replimune Group (REPL) stake by 35% in Q1 2026, buying an estimated $10.4K and bringing the position to 5,257 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

Allworth Financial first reported a position in REPL in Q3 2022 and has held it in 14 quarters since. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Allworth Financial held 5,257 shares of Replimune Group worth $40.2K as of Q1 2026.
  • Allworth Financial bought 1,358 Replimune Group shares in Q1 2026, an estimated $10.4K.
  • Replimune Group made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #2490 holding.
  • Allworth Financial first reported a position in Replimune Group in Q3 2022 and has held it in 14 quarters since.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.